Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Anticancer Research|February 26, 2004
Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma modelS D Shnyder, P A Cooper, N Gyselinck, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)A M Burger, P M Loadman, D E Thurston, et al.
Journal of Pharmacological and Toxicological Methods|May 17, 2011
Use of the hollow fiber assay for the evaluation of DNA damaging agentsJ Pedro Veiga, Patricia A Cooper, Klaus Pors, et al.
Msphere|February 23, 2022
Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition AssaysDavid C Bibby, Michael Savanovic, Jinrong Zhang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumoursM C Bibby, B J McDermott, J A Double, et al.
Journal of Chromatography|March 22, 1985
Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimensB J McDermott, J A Double, M C Bibby, et al.
Cancer Chemotherapy and Pharmacology|June 26, 2013
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rateRuth Duncan, Yee-Nee Sat-Klopsch, Angelika M Burger, et al.
Molecular Cancer Therapeutics|January 7, 2005
In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazolesChee Onn Leong, Marie Suggitt, David J Swaine, et al.
Journal of the National Cancer Institute|March 1, 1987
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animalsM C Bibby, J A Double, S A Ali, et al.
The Biochemical Journal|April 25, 2003
Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequenceAngie F Kirwan, Ashley C Bibby, Thierry Mvilongo, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Anticancer Research|February 26, 2004
Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma modelS D Shnyder, P A Cooper, N Gyselinck, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)A M Burger, P M Loadman, D E Thurston, et al.
Journal of Pharmacological and Toxicological Methods|May 17, 2011
Use of the hollow fiber assay for the evaluation of DNA damaging agentsJ Pedro Veiga, Patricia A Cooper, Klaus Pors, et al.
Msphere|February 23, 2022
Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition AssaysDavid C Bibby, Michael Savanovic, Jinrong Zhang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumoursM C Bibby, B J McDermott, J A Double, et al.
Journal of Chromatography|March 22, 1985
Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimensB J McDermott, J A Double, M C Bibby, et al.
Cancer Chemotherapy and Pharmacology|June 26, 2013
Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rateRuth Duncan, Yee-Nee Sat-Klopsch, Angelika M Burger, et al.
Molecular Cancer Therapeutics|January 7, 2005
In vitro, in vivo, and in silico analyses of the antitumor activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazolesChee Onn Leong, Marie Suggitt, David J Swaine, et al.
Journal of the National Cancer Institute|March 1, 1987
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animalsM C Bibby, J A Double, S A Ali, et al.
The Biochemical Journal|April 25, 2003
Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequenceAngie F Kirwan, Ashley C Bibby, Thierry Mvilongo, et al.
Pageof 21